CXCL12 and diabetes mellitus: A human EC line treated with normal or uremic sera from end-stage renal disease (ESRD) patients with diabetes and/or hypertension showed an upregulated expression of known inflammation markers such as MCP-1 and stromal cell-derived factor 1 (SDF-1), as compared to cells incubated with healthy sera [55].